Related Experiment Videos
[Progressive systemic scleroderma. Clinical spectrum and prognostic parameters in 131 patients]
Deutsche Medizinische Wochenschrift (1946)
|September 14, 1984
Summary
This study analyzed 131 patients with progressive systemic scleroderma, finding that disease severity and organ involvement increase with cutaneous involvement extent. Systemic inflammation signs correlate with a severe clinical course.
Area of Science:
- Rheumatology
- Dermatology
- Internal Medicine
Background:
- Progressive systemic scleroderma, a chronic autoimmune disease, affects connective tissues.
- Understanding its clinical course and organ involvement is crucial for patient management.
Purpose of the Study:
- To analyze the clinical course of progressive systemic scleroderma.
- To classify patients based on cutaneous involvement and assess organ damage.
- To investigate the association between systemic inflammation and disease severity.
Main Methods:
- Analysis of data from 131 patients with progressive systemic scleroderma.
- Classification into three types based on the extent of cutaneous involvement (Type I, II, III).
- Subdivision based on the presence or absence of systemic inflammation signs.
Main Results:
- Disease onset typically between 30-50 years, peaking around 40.
- Oesophageal (84%) and lung (56%) involvement were most common.
- Organ involvement severity increased from Type I to Type III.
- Systemic inflammation signs were linked to a more severe disease course.
Conclusions:
- Cutaneous involvement extent is a key factor in progressive systemic scleroderma progression.
- Systemic inflammation is a significant indicator of a severe clinical outcome.
- Early identification and classification aid in predicting disease trajectory.